- Last edited on December 4, 2023
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Last revision Both sides next revision | ||
meds:antidepressants:snri:v-desvenlafaxine [on May 16, 2019] |
meds:antidepressants:snri:v-desvenlafaxine [on December 4, 2023] psychdb [Pearls] |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== Desvenlafaxine (Pristiq) ====== | ====== Desvenlafaxine (Pristiq) ====== | ||
+ | {{INLINETOC}} | ||
+ | |||
+ | ===== Primer ===== | ||
+ | <WRAP group> | ||
+ | <WRAP half column> | ||
+ | **Desvenlafaxine** (Trade name: //Pristiq//) is an [[meds:antidepressants:home|antidepressant]] in the [[meds:antidepressants:snri:home|serotonin norepinephrine reuptake inhibitor (SNRI)]] class used in the treatment of [[mood:1-depression:home|major depressive disorder]]. | ||
+ | </WRAP> | ||
+ | <WRAP half column> | ||
+ | <catlist meds:antidepressants:snri: -columns:1 -noAddPageButton -sortAscending -noNSInBold> | ||
+ | </WRAP> | ||
+ | </WRAP> | ||
+ | |||
+ | ===== Dosing ===== | ||
* Starting dose: 50mg | * Starting dose: 50mg | ||
* Max dose: 100mg | * Max dose: 100mg | ||
+ | |||
+ | ===== Pearls ===== | ||
+ | * The elimination of desvenlafaxine is independent of CYP2D6 (unlike venlafaxine), which may be a potential advantage over venlafaxine for some patients in terms of drug–drug interactions and tolerability | ||
+ | * Venlafaxine is converted to desvenlafaxine via CYP 2D6 |